The frequency of immunoreactivity score (IRS) of sphingosine kinase 1 (SphK1) and sphingosine kinase 2 (SphK2) has been calculated with different clinicopathological attributes of oral squamous cell carcinoma patients. Here, SPHK2 is linked to oral cavity squamous cell carcinoma.